Cambridge Investment Research Advisors’s Lyra Therapeutics LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-831
Closed -$259K 3384
2024
Q1
$259K Buy
+831
New +$259K ﹤0.01% 2824